Regulatory Capability Blenheim Pharmacal, Inc. operates as a fully registered FDA and DEA facility with licensure across 35+ State Boards of Pharmacy, indicating strong compliance and the ability to handle regulated packaging and repackaging projects for pharmaceutical, nutraceutical, and OTC products.

Specialized Packaging The company focuses on contract packaging and repackaging of solid dose pharmaceuticals, nutraceuticals, and OTCs, including private labeling and custom packaging, which presents opportunities to upsell end-to-end packaging services and specialized containment for antibiotics in controlled facilities.

Small-to-Mid Market Advantage With 11-50 employees and annual revenue in the low to mid six-figures to potentially high six-figures range, BPI is positioned to be a nimble partner for niche or regional brands seeking reliable packaging and repackaging capacity without large-scale vendor management.

Facility and Compliance Fit Dedicated separate controlled facilities for solid dose antibiotic repackaging and packaging suggest a capability for cleanroom-like operations and product safety requirements, enabling collaboration on sensitive or regulated products that demand stringent handling.

Growth and Partnerships Operating in Upstate New York with a modern tech stack for website and digital operations, there are opportunities to expand clients in the pharma, nutraceutical, and OTC spaces through private labeling, white-label packaging, and scalable repackaging programs tailored to regional manufacturers or contract manufacturing organizations seeking reliable packaging capacity.